Teva, still searching for ‘world-class’ CEO, officially puts women’s health, cancer on the block chelfand Thu, 05/11/2017 – 11:16 More: Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block Source: fierce
read moreFresh off an M&A spree, Mylan may need another buy to keep growing: analyst esagonowsky Thu, 05/11/2017 – 11:03 More: Fresh off an M&A spree, Mylan may need another buy to keep growing: analyst Source: fierce
read moreJohnson & Johnson appeal of $72M talc verdict could hinge on Bristol-Myers Squibb’s SCOTUS case esagonowsky Thu, 05/11/2017 – 09:58 More: Johnson & Johnson appeal of M talc verdict could hinge on Bristol-Myers Squibb's SCOTUS case Source: fierce
read moreLupin completes major expansion of U.S. manufacturing facility epalmer Thu, 05/11/2017 – 08:35 More: Lupin completes major expansion of U.S. manufacturing facility Source: fierce
read moreGlaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura chelfand Thu, 05/11/2017 – 08:14 More: Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura Source: fierce
read moreAbbVie’s glecaprevir/pibrentasvir (G/P) has become the first treatment for chronic hepatitis C to be included in the UK’s Early Access to Medicines Scheme (EAMS). More: UK patients get early access to AbbVie’s hepatitis regimen Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals